Quantum Biopharma购买了价值100万美元的比特币和其他加密货币

根据5月19日的新闻稿，该购买的价格将Quantum的总加密货币持有量达到约450万美元。

Canadian biotechnology company Quantum Biopharma has purchased an additional $1 million worth of Bitcoin and other cryptocurrencies.

加拿大生物技术公司Quantum Biopharma购买了价值100万美元的比特币和其他加密货币。

The buys take Quantum’s total cryptocurrency holdings to approximately $4.5 million, according to a May 19 announcement. The biotech company plans to stake a portion of its crypto to generate revenue.

根据5月19日的公告，该购买的价格将Quantum的总加密货币持有量达到约450万美元。这家生物技术公司计划将一部分加密货币存储以产生收入。

Quantum expects that holding a treasury of Bitcoin (BTC) and other crypto assets will “provide a return on investment for shareholders and […] provide some hedge against the Canadian dollar,” it said.

Quantum预计，持有比特币（BTC）的国库，而其他加密资产将“为股东提供投资回报，[…]对加拿大美元提供了对冲，”它说。

Shares of Quantum’s stock, QNTM, rose by approximately 25% following the announcement, according to data from Google Finance.

根据Google Finance的数据，宣布这一消息后，量子股票QNTM的股票增长了约25％。

Related: Basel Medical shares down 15% on $1B Bitcoin buying plans

相关：巴塞尔医疗股价下跌了15％，$ 1B比特币购买计划

Quantum is one of several healthcare companies accumulating Bitcoin as corporate crypto treasuries become increasingly popular.

随着公司加密库库变得越来越流行，量子是积累比特币的几家医疗保健公司之一。

In March, NASDAQ-listed biopharmaceutical company Atai Life Sciences tipped plans to buy $5 million worth of Bitcoin.

3月，纳斯达克上市的生物制药公司Atai Life Sciences提出了购买价值500万美元的比特币的计划。

In a March 20 X post, Atai’s founder, Christian Angermayer, said “Bitcoin should be a part of ANY corporate treasury – especially, in fact, in the biotech sector.”

Atai的创始人Christian Angermayer在3月20日的帖子中说：“比特币应该是任何公司财政部的一部分，尤其是实际上，在生物技术领域。”

Angermayer added in a blog post that Bitcoin can help the biotech hedge against inflation and stay solvent during the long periods before drug approvals.

Angermayer在博客文章中补充说，比特币可以帮助生物技术对冲通货膨胀，并在毒品批准之前长期保持溶剂。

On May 16, Singapore-based healthcare company Basel Medical Group announced plans to buy $1 billion worth of Bitcoin.

5月16日，总部位于新加坡的医疗保健公司巴塞尔医疗集团（Basel Medical Group）宣布计划购买价值10亿美元的比特币。

It said a Bitcoin treasury will support its plans to expand in Asia through acquisitions by giving Basel “one of the strongest balance sheets among Asia-focused healthcare providers.”

它说，比特币财政部将通过收购来支持其在亚洲扩展的计划，这是巴塞尔“以亚洲为中心的医疗保健提供者中最强大的资产负债表之一”。

Unlike Quantum, however, Basel’s shares dropped significantly on the day of the announcement.

但是，与Quantum不同，巴塞尔的股票在宣布当天大幅下降。

Collectively, corporate treasuries hold more than $83 billion in Bitcoin as of May 19, according to data from BitcoinTreasuries.NET.

根据BitCoinReasuries.net的数据，截至5月19日，企业库库截至5月19日持有超过830亿美元的比特币。

Publicly traded companies are now the largest institutional Bitcoin holders after exchange-traded funds (ETFs), the data shows.

数据显示，公开交易的公司现在是交易所交易基金（ETF）之后最大的机构比特币持有者。

Bitcoin can “potentially be a valuable hedge against growing fiscal deficits, currency debasement, and geopolitical risks” for companies, asset manager Fidelity Digital Assets said in a 2024 report.

资产经理Fidelity Digital Assets在2024年的一份报告中说，比特币“有可能成为不断增长的财政缺陷，货币贬低和地缘政治风险的宝贵对冲”。